Cite
HARVARD Citation
Yang, H. et al. (2022). Systematic review with meta‐analysis: loss of response and requirement of ustekinumab dose escalation in inflammatory bowel diseases. Alimentary pharmacology & therapeutics. 55 (7), pp. 764-777. [Online].